Andra AP fonden Has $2.03 Million Position in Core Laboratories N.V. (CLB)

Andra AP fonden increased its holdings in Core Laboratories N.V. (NYSE:CLB) by 157.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,600 shares of the oil and gas company’s stock after purchasing an additional 12,600 shares during the quarter. Andra AP fonden’s holdings in Core Laboratories N.V. were worth $2,033,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Parallel Advisors LLC increased its position in shares of Core Laboratories N.V. by 13.1% in the second quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock valued at $101,000 after acquiring an additional 117 shares during the period. The Manufacturers Life Insurance Company increased its position in shares of Core Laboratories N.V. by 63.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after acquiring an additional 439 shares during the period. Shine Investment Advisory Services Inc. purchased a new position in shares of Core Laboratories N.V. in the second quarter valued at about $134,000. Advisory Services Network LLC increased its position in shares of Core Laboratories N.V. by 33.3% in the second quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock valued at $138,000 after acquiring an additional 341 shares during the period. Finally, First Bank & Trust increased its position in shares of Core Laboratories N.V. by 5.8% in the second quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after acquiring an additional 82 shares during the period.

A number of equities analysts have issued reports on CLB shares. Deutsche Bank AG started coverage on shares of Core Laboratories N.V. in a research report on Tuesday, October 10th. They issued a “buy” rating and a $109.00 price objective on the stock. Zacks Investment Research cut shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. Scotiabank set a $136.00 price objective on shares of Core Laboratories N.V. and gave the company a “hold” rating in a research report on Wednesday, October 25th. Royal Bank Of Canada decreased their price objective on shares of Core Laboratories N.V. from $115.00 to $112.00 and set an “outperform” rating on the stock in a research report on Thursday, September 7th. Finally, ValuEngine cut shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a research report on Friday, September 1st. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $108.64.

Shares of Core Laboratories N.V. (NYSE:CLB) opened at $105.40 on Friday. The firm has a market cap of $4,653.09, a PE ratio of 57.60 and a beta of 1.57. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.81 and a current ratio of 2.18. Core Laboratories N.V. has a 52 week low of $86.55 and a 52 week high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings data on Monday, October 23rd. The oil and gas company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.44 by $0.04. Core Laboratories N.V. had a net margin of 12.06% and a return on equity of 52.89%. The business had revenue of $166.20 million for the quarter, compared to analyst estimates of $160.94 million. During the same quarter in the previous year, the firm posted $0.38 earnings per share. Core Laboratories N.V.’s quarterly revenue was up 1.4% on a year-over-year basis. sell-side analysts forecast that Core Laboratories N.V. will post 1.99 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 21st. Investors of record on Friday, October 20th will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Thursday, October 19th. Core Laboratories N.V.’s payout ratio is currently 126.44%.

ILLEGAL ACTIVITY WARNING: “Andra AP fonden Has $2.03 Million Position in Core Laboratories N.V. (CLB)” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/11/12/andra-ap-fonden-has-2-03-million-position-in-core-laboratories-n-v-clb.html.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply